US2007142641A1PendingUtilityA1
Atazanavir conjugates and antibodies useful in immunoassay
Assignee: ROCHE DIAGNOSTICS OPERATIONSPriority: Jul 13, 2001Filed: Dec 22, 2006Published: Jun 21, 2007
Est. expiryJul 13, 2021(expired)· nominal 20-yr term from priority
C07K 16/38C07K 16/44C07D 213/42
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Activated haptens useful for generating immunogens to the HIV protease inhibitor atazanavir, immunogens useful for producing antibodies to atazanavir, and antibodies and labeled conjugates useful in immunoassays for determination of atazanavir. The haptens feature an activated functionality at the central, non-terminal hydroxyl group.
Claims
exact text as granted — not AI-modified1 . A compound having the structure
wherein Y is O, m is 0, L is a linker comprising 0 carbon atoms, and A is an activated ester.
2 . A compound having the structure
wherein Y is O, S, or NH, m is 1, L is a linker comprising from 1 to 40 carbon atoms arranged in a straight chain or a branched chain, saturated or unsaturated, an containing up to two ring structures and 0-20 heteroatoms, with the proviso that not more than two heteroatoms may be linked in sequence, and A is an activated ester.Join the waitlist — get patent alerts
Track US2007142641A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.